Literature DB >> 19519163

The soluble nickel component of residual oil fly ash alters pulmonary host defense in rats.

Jenny R Roberts1, Shih-Houng Young, Vincent Castranova, James M Antonini.   

Abstract

The soluble metal fraction of residual oil fly ash (ROFA) has been shown to increase the susceptibility to infection in animal models. The goal of this study was to determine which of the primary soluble metals or metal combinations in ROFA were responsible for the increased infectivity. The soluble fraction of ROFA contained Ni, Fe, Al, and Zn. On Day 0, Sprague-Dawley rats were intratracheally (IT) instilled with NiCl2 (55.7 microg/rat), FeSO4 (32.7 microg/rat), Al3(SO4)2 (46.6 microg/rat), or ZnCl2 (8.69 microg/rat), or a combination of all the metals (Total Mixture). In a separate experiment, rats were instilled with metal mixtures, including the total mixture, and mixtures without Fe (Mix--No Fe), Ni (Mix--No Ni), Al (Mix--No Al), or Zn (Mix--No Zn). At Day 3, rats were instilled with 5 x 10(4) Listeria monocytogenes. At Days 6, 8 and 10, left lungs were removed to assess bacterial clearance. Bronchoalveolar lavage (BAL) was performed on right lungs on Day 3, before infection, and on Days 6, 8 and 10 to assess lung injury and cellular activity. Prior to infection, soluble Ni and mixtures containing Ni significantly increased lung injury, inflammation, and oxidative damage to a comparable degree when compared to control. Post-infection, rats pre-treated with soluble Ni, alone or in a metal mixture, had increased bacterial lung burden on Day 6, and body weight decreased in the soluble Ni, Mix--No Fe, and Mix--No Al groups post-infection, indicating Fe and Al may act antagonistically to Ni. Ni alone and in metal mixtures increased reactive oxidants in the lung and appeared to be the most important factor in suppressing T-cell activity post-infection. Soluble Ni is likely the primary metal involved in the increased susceptibility to infection observed in rats exposed to the soluble metals of ROFA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519163     DOI: 10.1080/15476910802630379

Source DB:  PubMed          Journal:  J Immunotoxicol        ISSN: 1547-691X            Impact factor:   3.000


  5 in total

1.  Susceptibility to inhaled flame-generated ultrafine soot in neonatal and adult rat lungs.

Authors:  Jackie K W Chan; Michelle V Fanucchi; Donald S Anderson; Aamir D Abid; Christopher D Wallis; Dale A Dickinson; Benjamin M Kumfer; Ian M Kennedy; Anthony S Wexler; Laura S Van Winkle
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

2.  Acute exposure to air pollution particulate matter aggravates experimental myocardial infarction in mice by potentiating cytokine secretion from lung macrophages.

Authors:  Timoteo Marchini; Dennis Wolf; Nathaly Anto Michel; Maximilian Mauler; Bianca Dufner; Natalie Hoppe; Jessica Beckert; Markus Jäckel; Natalia Magnani; Daniel Duerschmied; Deborah Tasat; Silvia Alvarez; Jochen Reinöhl; Constantin von Zur Muhlen; Marco Idzko; Christoph Bode; Ingo Hilgendorf; Pablo Evelson; Andreas Zirlik
Journal:  Basic Res Cardiol       Date:  2016-05-30       Impact factor: 17.165

3.  Lung Toxicity Analysis of Nano-Sized Kaolin and Bentonite: Missing Indications for a Common Grouping.

Authors:  Martin Wiemann; Antje Vennemann; Wendel Wohlleben
Journal:  Nanomaterials (Basel)       Date:  2020-01-24       Impact factor: 5.076

4.  Effects of Eyjafjallajökull volcanic ash on innate immune system responses and bacterial growth in vitro.

Authors:  Martha M Monick; Jonas Baltrusaitis; Linda S Powers; Jennifer A Borcherding; Juan C Caraballo; Imali Mudunkotuwa; David W Peate; Katherine Walters; Jay M Thompson; Vicki H Grassian; Gunnar Gudmundsson; Alejandro P Comellas
Journal:  Environ Health Perspect       Date:  2013-03-11       Impact factor: 9.031

5.  Coal fly ash impairs airway antimicrobial peptides and increases bacterial growth.

Authors:  Jennifer A Borcherding; Haihan Chen; Juan C Caraballo; Jonas Baltrusaitis; Alejandro A Pezzulo; Joseph Zabner; Vicki H Grassian; Alejandro P Comellas
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.